Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

43,528 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.
Shack S, Miller A, Liu L, Prasanna P, Thibault A, Samid D. Shack S, et al. Among authors: liu l. Clin Cancer Res. 1996 May;2(5):865-72. Clin Cancer Res. 1996. PMID: 9816242
p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ. Huang S, et al. Among authors: liu ln. Cancer Res. 2001 Apr 15;61(8):3373-81. Cancer Res. 2001. PMID: 11309295
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ. Hosoi H, et al. Among authors: liu ln. Cancer Res. 1999 Feb 15;59(4):886-94. Cancer Res. 1999. PMID: 10029080
Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN, Dias P, Houghton PJ. Liu LN, et al. Cell Growth Differ. 1998 Sep;9(9):699-711. Cell Growth Differ. 1998. PMID: 9751114
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.
Walls R, Thibault A, Liu L, Wood C, Kozlowski JM, Figg WD, Sampson ML, Elin RJ, Samid D. Walls R, et al. Among authors: liu l. Prostate. 1996 Sep;29(3):177-82. doi: 10.1002/(SICI)1097-0045(199609)29:3<177::AID-PROS3>3.0.CO;2-B. Prostate. 1996. PMID: 8827086
Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs.
Pineau T, Hudgins WR, Liu L, Chen LC, Sher T, Gonzalez FJ, Samid D. Pineau T, et al. Among authors: liu l. Biochem Pharmacol. 1996 Aug 23;52(4):659-67. doi: 10.1016/0006-2952(96)00340-1. Biochem Pharmacol. 1996. PMID: 8759039
Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
Prasanna P, Thibault A, Liu L, Samid D. Prasanna P, et al. Among authors: liu l. J Neurochem. 1996 Feb;66(2):710-6. doi: 10.1046/j.1471-4159.1996.66020710.x. J Neurochem. 1996. PMID: 8592143
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
Samid D, Ram Z, Hudgins WR, Shack S, Liu L, Walbridge S, Oldfield EH, Myers CE. Samid D, et al. Among authors: liu l. Cancer Res. 1994 Feb 15;54(4):891-5. Cancer Res. 1994. PMID: 8313377
Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.
Liu L, Shack S, Stetler-Stevenson WG, Hudgins WR, Samid D. Liu L, et al. J Invest Dermatol. 1994 Sep;103(3):335-40. doi: 10.1111/1523-1747.ep12394874. J Invest Dermatol. 1994. PMID: 8077698
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.
Liu L, Hudgins WR, Miller AC, Chen LC, Samid D. Liu L, et al. Cytokine. 1995 Jul;7(5):449-56. doi: 10.1006/cyto.1995.0061. Cytokine. 1995. PMID: 7578983
43,528 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback